Biologic and Systemic Agents in Dermatology

Home

/

Specialità

/

Dermatologia

/

Biologic and Systemic Agents in Dermatology

Editore

Springer

Anno

2018

Pagine

574

ISBN

9783319668833

I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.

Dettagli Indice Recensioni (0)

Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agents in the field of dermatology. In the past decade, there have been several groundbreaking advances in medical dermatology. Novel biologic and systemic agents have been developed to treat inflammatory disorders, including psoriasis and atopic dermatitis, as well as skin malignancies such as melanoma.

Biologic and Systemic Agents in Dermatology encompasses these developments by describing the mechanism of action of these various agents and the clinical efficacy and safety to treating these respective disorders. The utilization of biologic and systemic agents in other dermatologic conditions, pharmacoeconomics, pharmacovigilance, and clinical trials outcomes are discussed as well as topics including tumor necrosis, conventional systemic agents for psoriatic disease, and oral agents for atopic dermatitis.

History of Therapies in Dermatology: Past to Present

Voorhees, Abby S., MD (et al.)

Pages 1-6
Outcome Measures in Psoriasis and Atopic Eczema

Duffin, Kristina Callis, MD, MS

Pages 7-25
Interpreting Clinical Trial Data

Amin, Mina, BS (et al.)

Pages 27-36
Compliance and Persistency

Boes, Emily, D.O. (et al.)

Pages 37-49
Quality of Life in the Dermatology Practice

Cather, Jennifer, MD (et al.)

Pages 51-55

Medical Legal Issues with Biologic Agents in the Treatment of Psoriasis

Goldberg, David J., MD, JD (et al.)

Pages 57-60
Patient and Physician Perspectives on Traditional Systemic and Biologic Therapies for Psoriasis

Midura, Margaretta, BA (et al.)

Pages 61-64
Outcomes of Comorbidities with Biologic and Systemic Agents

Noe, Megan H., MD, MPH (et al.)

Pages 65-71
Pharmacovigilance

Kalb, Robert E., MD

Pages 73-82
Pharmacoeconomics of Systemic and Biologic Therapy in Dermatology

Porter, Martina L., MD (et al.)

Pages 83-91
Immunogenicity of Biologic Agents in Psoriasis

Florek, Alexandra G., MD (et al.)

Pages 93-99
Manufacturing of Biologics

Nathan, Jared J., BS chemistry (et al.)

Pages 101-110
Tumor Necrosis Factor Inhibition

Papp, K. A., MD, PhD (et al.)

Pages 111-121
Dual Inhibition of IL-12/IL-23 and Selective Inhibition of IL-23 in Psoriasis

Blauvelt, Andrew, MD, MBA

Pages 123-131
Interleukin-17 Inhibition for the Treatment of Inflammatory Skin Disease

Hawkes, Jason E., MD (et al.)

Pages 133-144
Systemic Therapies in Psoriasis

Peterson, Gregory, MD (et al.)

Pages 145-158
Nail, Scalp, and Palmoplantar Psoriasis

Crowley, Jeffrey J., MS, MD, FAAD

Pages 159-174
Current and Emerging Treatments for Psoriatic Arthritis

Mease, Philip J., M.D.

Pages 175-185
Janus Kinase Inhibitors

Kim, Andrew, MD (et al.)

Pages 187-198
Fumaric Acid Esters in Dermatology

Lee, Katrina, BS (et al.)

Pages 199-208
Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions

Huber, Jordan, MD (et al.)

Pages 209-219
Oral Retinoids in Dermatology

Nakamura, Mio, MD (et al.)

Pages 221-231
Combination Therapy with Biologics and Other Systemic Treatments in Psoriasis

Yim, Kaitlyn M., BA (et al.)

Pages 233-240
Transitioning Biologic and Systemic Therapies in Psoriatic Patients

Bagel, Jerry, MD, MS

Pages 241-243
Practical Considerations and Complex Cases in Psoriasis

Yamauchi, Paul S., MD, PhD

Pages 245-252

Biosimilars in Dermatology

Yamauchi, Paul S., MD, PhD

Pages 253-266
Biological Agents in Pediatric Dermatology

Lund, Emily B., MD (et al.)

Pages 267-271
Oral Systemic Agents in Pediatric Dermatology

Cheng, Nancy, MD (et al.)

Pages 273-280
Utilization of Biologic and Systemic Agents in the Elderly

Hoy, Alexander S., BS (et al.)

Pages 281-294
Miscellaneous Uses of Biologic and Systemic Agents in Other Dermatologic Conditions

Kimmel, Grace W., MD (et al.)

Pages 295-308
Biologics for the Treatment of Atopic Dermatitis

Hajar, Tamar, MD (et al.)

Pages 309-317
Oral Agents for Atopic Dermatitis: Current and in Development

Mayba, Julia, BSc (et al.)

Pages 319-330
Cutaneous T-Cell Lymphoma

Chung, Catherine G., MD (et al.)

Pages 331-342
Anti-CD20 Agents and Potential Novel Biologics in Pemphigus Vulgaris and Other Autoimmune Blistering Diseases

Huang, Amy, MD (et al.)

Pages 343-349
Oral Systemic Agents for Immunobullous Disorders

Patton, Timothy, DO (et al.)

Pages 351-364
Biologic and Systemic Agents in Hidradenitis Suppurativa

Okun, Martin M., MD, PhD

Pages 365-376
Systemic and Biologic Agents for Lupus Erythematosus

Wallace, Daniel J., MD, FACP, MACR

Pages 377-390
Anti-IgE Therapy

Maderal, Andrea D., MD (et al.)

Pages 391-399
Role of Intravenous Immunoglobulin in Dermatologic Disorders

Amber, Kyle T., BA (et al.)

Pages 401-423
Systemic Antifungals

Oak, Allen S. W., MD (et al.)

Pages 425-450
Systemic Antivirals in Dermatology

Jarad Peranteau, A., MD (et al.)

Pages 451-470
Anthelmintics in Dermatology

Worswick, Scott, MD (et al.)

Pages 471-494
Systemic Therapies for Scarring and Non-scarring Alopecia

Goh, Carolyn, MD

Pages 495-515
Dapsone in Dermatology

Abramovits, William, MD, FAAD

Pages 517-524
Systemic Nonantibiotic Therapy in Acne and Rosacea

Webster, Guy, MD, PhD

Pages 525-529

Oral Antibiotics in Dermatology: A Practical Overview with Clinically Relevant Correlations and Management Suggestions

Rosso, James Q., DO, FAOCD, FAAD (et al.)

Pages 531-539
Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma

Armstrong, Patrick, MD (et al.)

Pages 541-548
Update in Immunotherapies for Melanoma

Martin, Sabrina, MD, PhD (et al.)

Pages 549-552
Patient Advocacy Organizations

Coman, Catie, MA

Pages 553-555